Inovio Pharmaceuticals, Inc. (INO)
1.16
-0.03
(-2.52%)
USD |
NASDAQ |
Apr 16, 16:00
1.17
+0.01
(+0.86%)
After-Hours: 04:25
Inovio Pharmaceuticals Free Cash Flow : -88.92M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| ADMA Biologics, Inc. | 27.50M |
| Vaxart, Inc. | 7.569M |
| Capricor Therapeutics, Inc. | -81.54M |
| Allogene Therapeutics, Inc. | -149.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.37M |
| Cash from Investing (Quarterly) | -0.0582M |
| Cash from Financing (Quarterly) | 27.13M |
| Free Cash Flow Per Share (Quarterly) | -0.2826 |
| Free Cash Flow to Equity (Quarterly) | -18.85M |
| Free Cash Flow to Firm (Quarterly) | -19.50M |
| Free Cash Flow Yield | -154.4% |